Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

190 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Effectiveness and Safety of Adalimumab in Patients With Very Early-Onset Inflammatory Bowel Disease: A Retrospective Study on Behalf of the Porto Inflammatory Bowel Disease Working Group of European Society for Pediatric Gastroenterology Hepatology and Nutrition.
Weintraub Y, Collen LV, Hussey S, Mitrova K, Machta JS, Kang B, Granot M, D'Arcangelo G, Spencer EA, Kolho KL, Yeh PJ, Sladek M, Scarallo L, Palomino L, Afzal NA, de Laffolie J, Miele E, Bramuzzo M, Olén O, Russell RK, Rohani P, Tzivinikos C, Urlep D, van Rheenen PF, de Ridder L, Yogev D, Schneider AM, Cohen S, Garcia-Romero R, Dipasquale V, Uhlig HH, Shouval DS. Weintraub Y, et al. Among authors: olen o. Inflamm Bowel Dis. 2025 Jan 15:izae302. doi: 10.1093/ibd/izae302. Online ahead of print. Inflamm Bowel Dis. 2025. PMID: 39813158
Modified Crohn's Disease Exclusion Diet Maintains Remission in Pediatric Crohn's Disease; Randomized Controlled Trial.
Sigall Boneh R, Navas-López VM, Hussey S, Pujol-Muncunill G, Lawrence S, Rolandsdotter H, Otley A, Martín-de-Carpi J, Abramas L, Herrador-López M, Castillo NE, Chen M, Hurley M, Wingate K, Olen O, Rääf TE, Yaakov M, Wierdsma N, Van Limbergen J, Wine E. Sigall Boneh R, et al. Among authors: olen o. Clin Gastroenterol Hepatol. 2024 Dec 26:S1542-3565(24)01131-5. doi: 10.1016/j.cgh.2024.12.006. Online ahead of print. Clin Gastroenterol Hepatol. 2024. PMID: 39732356 Free article.
Response to Dai et al.
Karlqvist S, Sachs MC, Eriksson C, Cao Y, Montgomery S, Ludvigsson JF, Olén O, Halfvarson J. Karlqvist S, et al. Among authors: olen o. Am J Gastroenterol. 2025 Jan 1;120(1):260-261. doi: 10.14309/ajg.0000000000003199. Am J Gastroenterol. 2025. PMID: 39718002 No abstract available.
Comparative Risk of Serious Infection With Vedolizumab vs Anti-Tumor Necrosis Factor in Inflammatory Bowel Disease: Results From Nationwide Swedish Registers.
Karlqvist S, Sachs MC, Eriksson C, Cao Y, Montgomery S, Ludvigsson JF, Olén O, Halfvarson J; SWIBREG Study Group. Karlqvist S, et al. Among authors: olen o. Am J Gastroenterol. 2024 Dec 1;119(12):2480-2492. doi: 10.14309/ajg.0000000000002961. Epub 2024 Jul 12. Am J Gastroenterol. 2024. PMID: 38994835 Free PMC article.
190 results